Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on clinicaltrials.gov

Health Affairs

Volumn 30, Issue 12, 2011, Pages 2338-2345

  Law, Michael R ^a   Kawasumi, Yuko ^a   Morgan, Steven G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; BIOLOGICAL FUNCTIONS; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; LAW; ORGANIZATION; REFERENCE DATABASE; RETROSPECTIVE STUDY; UNITED STATES;

EID: 84855661185     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.0172     Document Type: Article

References (26)

1. McGauran N, Wieseler B, Kreis J, Schüler Y-B, Kölsch H, Kaiser T. Reporting bias in medical research-a narrative review. Trials. 2010; 11(1):37.
2. Zarin DA, Tse T. Moving toward transparency of clinical trials. Science. 20087;319(5868):1340-2.
3. Chan A-W, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004; 291(20):2457-65.
4. Dickersin K, Rennie D. Registering clinical trials. JAMA. 2003;290(4): 516-23.
5. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-60.
6. Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005;353(26):2779-87.
7. Zarin DA, Ide NC, Tse T, Harlan WR, West JC, Lindberg DAB. Issues in the registration of clinical trials. JAMA. 2007;297(19):2112-20.
8. Tse T, Williams RJ, Zarin DA. Reporting "basic results" in Clinical Trials.gov. Chest. 2009;136(1): 295-303.
9. Miller JD. Registering clinical trial results: the next step. JAMA. 2010;303(8):773-4.
10. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002; 27(4):299-309.
11. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA. 2009;302(9):977-84.
12. Levin LA, Palmer JG. Institutional review boards should require clinical trial registration. Arch Intern Med. 2007;167(15):1576-80.
13. Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, Califf RM, et al. Ethical and scientific implications of the globalization of clinical research. N Engl J Med. 2009;360(8):816-23.
14. Pharmaceutical Research and Manufacturers of America. Pharmaceutical industry profile 2011 [Internet]. Washington (DC): PhRMA; 2011 [cited 2011 Oct 26]. Available from: http://www.phrma.org/sites/default/files/159/phrma_profile_2011_final.pdf
15. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356(24):2457-71.
16. Bourgeois FT, Murthy S, Mandl KD. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med. 2010;153(3): 158-66.
17. Ewart R, Lausen H, Millian N. Undisclosed changes in outcomes in randomized controlled trials: an observational study. Ann Fam Med. 2009;7(6):542-6.
18. Reveiz L, Krleža-Jerić K, Chan A-W, De Aguiar S. Do trialists endorse clinical trial registration? Survey of a PubMed sample. Trials. 2007; 8(1):30.
19. Krleža-Jerić K. Clinical trial registration: the differing views of industry, the WHO, and the Ottawa Group. PLoS Med. 2005;2(11):e378.
20. Scherer M, Trelle S. Opinions on registering trial details: a survey of academic researchers. BMC Health Serv Res. 2008;8(1):18.
21. Berg JO. Clinical trial registries. JAMA. 2007;298(13):1514.
22. Majumdar SR, Almasi EA, Stafford RS. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA. 2004; 292(16):1983-8.
23. Legal Information Institute. U.S. Code: title 21, chapter 9, subchapter 3, section 331: prohibited acts [Internet]. Ithaca (NY): Cornell University Law School; [cited 2011 Oct 26]. Available from: http://www.law.cornell.edu/uscode/html/uscode21/usc_sec_21_00000331----000-.html
24. Blunt J. Research ethics committees must ensure registration of research and accessibility of results. BMJ. 1998;316(7127):312.
25. Food and Drug Administration. Informed consent elements. Fed Regist. 2009;74(248):68750-6.
26. Ramsey S, Scoggins J. Commentary: practicing on the tip of an information iceberg? Evidence of underpublication of registered clinical trials in oncology. Oncologist. 2008;13(9):925-9.